Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 381

1.

Forty-year trends in menopausal hormone therapy use and breast cancer incidence among postmenopausal black and white women.

Chlebowski RT, Aragaki AK, Anderson GL, Prentice RL.

Cancer. 2020 Mar 25. doi: 10.1002/cncr.32846. [Epub ahead of print]

PMID:
32212335
2.

Genetic predictors of circulating 25-hydroxyvitamin D and prognosis after colorectal cancer.

Neumeyer S, Butterbach K, Banbury BL, Berndt SI, Campbell PT, Chlebowski RT, Chan AT, Giovannucci EL, Joshi AD, Ogino S, Song M, McCullough ML, Maalmi H, Manson JE, Sakoda LC, Schoen RE, Slattery ML, White E, Win AK, Figueiredo JC, Hopper JL, Macrae FA, Peters U, Brenner H, Hoffmeister M, Newcomb PA, Chang-Claude J.

Cancer Epidemiol Biomarkers Prev. 2020 Mar 18. pii: cebp.1409.2019. doi: 10.1158/1055-9965.EPI-19-1409. [Epub ahead of print]

PMID:
32188599
3.

The Women's Health Initiative Estrogen-alone Trial had differential disease and medical expenditure consequences across age groups.

Donneyong MM, Chang TJ, Roth JA, Guilds M, Ankrah D, Najafzadeh M, Xu WY, Chlebowski RT, Margolis K, Manson JE.

Menopause. 2020 Mar 2. doi: 10.1097/GME.0000000000001517. [Epub ahead of print]

PMID:
32132440
4.

Trajectory of recurrent falls in post-menopausal breast cancer survivors and in matched cancer-free controls.

Pan K, Ray RM, Cauley JA, Shadyab AH, Hurria A, Chlebowski RT.

Breast Cancer Res Treat. 2020 Apr;180(3):767-775. doi: 10.1007/s10549-020-05576-8. Epub 2020 Feb 19.

PMID:
32076891
5.

The association of delay in curative intent treatment with survival among breast cancer patients: findings from the Women's Health Initiative.

Yung R, Ray RM, Roth J, Johnson L, Warnick G, Anderson GL, Kroenke CH, Chlebowski RT, Simon MS, Fung C, Pan K, Wang D, Barrington WE, Reding KW.

Breast Cancer Res Treat. 2020 Apr;180(3):747-757. doi: 10.1007/s10549-020-05572-y. Epub 2020 Feb 15.

PMID:
32062784
6.

Dietary Modification and Breast Cancer Mortality: Long-Term Follow-Up of the Women's Health Initiative Randomized Trial.

Chlebowski RT, Aragaki AK, Anderson GL, Pan K, Neuhouser ML, Manson JE, Thomson CA, Mossavar-Rahmani Y, Lane DS, Johnson KC, Wactawski-Wende J, Snetselaar L, Rohan TE, Luo J, Barac A, Prentice RL; Women’s Health Initiative.

J Clin Oncol. 2020 Feb 7:JCO1900435. doi: 10.1200/JCO.19.00435. [Epub ahead of print]

PMID:
32031879
7.

Postmenopausal Breast Cancer and Physical Function Change: A Difference-in-Differences Analysis.

Michael YL, Wu C, Pan K, Seguin-Fowler RA, Garcia DO, Zaslavsky O, Chlebowski RT.

J Am Geriatr Soc. 2020 Jan 24. doi: 10.1111/jgs.16323. [Epub ahead of print]

PMID:
31977067
8.

Low-fat dietary pattern and global cognitive function: Exploratory analyses of the Women's Health Initiative (WHI) randomized Dietary Modification trial.

Chlebowski RT, Rapp S, Aragaki AK, Pan K, Neuhouser ML, Snetselaar LG, Manson JE, Wactawski-Wende J, Johnson KC, Hayden K, Baker LD, Henderson VW, Garcia L, Qi L, Prentice RL.

EClinicalMedicine. 2020 Jan 8;18:100240. doi: 10.1016/j.eclinm.2019.100240. eCollection 2020 Jan.

9.

Association of Diet Quality and Physical Activity on Obesity-Related Cancer Risk and Mortality in Black Women: Results from the Women's Health Initiative.

Chebet JJ, Thomson CA, Kohler LN, Ehiri JE, Luo J, Cheng TD, Pan K, Chlebowski RT, Nassir R, Sealy-Jefferson S, Manson JE, Saquib N, Bell ML.

Cancer Epidemiol Biomarkers Prev. 2020 Mar;29(3):591-598. doi: 10.1158/1055-9965.EPI-19-1063. Epub 2020 Jan 8.

PMID:
31915146
10.

The association between DXA-derived body fat measures and breast cancer risk among postmenopausal women in the Women's Health Initiative.

Arthur RS, Xue X, Kamensky V, Chlebowski RT, Simon M, Luo J, Shadyab AH, Neuhouser ML, Banack H, Ho GYF, Lane DS, Pan K, Reding KW, Wassertheil-Smoller S, Dannenberg AJ, Rohan TE.

Cancer Med. 2020 Feb;9(4):1581-1599. doi: 10.1002/cam4.2690. Epub 2019 Dec 25.

11.

Intentional Weight Loss and Obesity-Related Cancer Risk.

Luo J, Hendryx M, Manson JE, Figueiredo JC, LeBlanc ES, Barrington W, Rohan TE, Howard BV, Reding K, Ho GY, Garcia DO, Chlebowski RT.

JNCI Cancer Spectr. 2019 Aug 9;3(4):pkz054. doi: 10.1093/jncics/pkz054. eCollection 2019 Dec.

12.

Menopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy: A Randomized Trial.

Manson JE, Aragaki AK, Bassuk SS, Chlebowski RT, Anderson GL, Rossouw JE, Howard BV, Thomson CA, Stefanick ML, Kaunitz AM, Crandall CJ, Eaton CB, Henderson VW, Liu S, Luo J, Rohan T, Shadyab AH, Wells G, Wactawski-Wende J, Prentice RL; WHI Investigators.

Ann Intern Med. 2019 Sep 10. doi: 10.7326/M19-0274. [Epub ahead of print]

PMID:
31499528
13.

Low-Fat Dietary Pattern and Cancer Mortality in the Women's Health Initiative (WHI) Randomized Controlled Trial.

Chlebowski RT, Anderson GL, Manson JE, Prentice RL, Aragaki AK, Snetselaar L, Beresford SAA, Kuller LH, Johnson K, Lane D, Luo J, Rohan TE, Jiao L, Barac A, Womack C, Coday M, Datta M, Thomson CA.

JNCI Cancer Spectr. 2019 Jan 7;2(4):pky065. doi: 10.1093/jncics/pky065. eCollection 2018 Oct.

14.

Association of Normal-Weight Central Obesity With All-Cause and Cause-Specific Mortality Among Postmenopausal Women.

Sun Y, Liu B, Snetselaar LG, Wallace RB, Caan BJ, Rohan TE, Neuhouser ML, Shadyab AH, Chlebowski RT, Manson JE, Bao W.

JAMA Netw Open. 2019 Jul 3;2(7):e197337. doi: 10.1001/jamanetworkopen.2019.7337.

15.

Insulin Resistance and Cancer-Specific and All-Cause Mortality in Postmenopausal Women: The Women's Health Initiative.

Pan K, Nelson RA, Wactawski-Wende J, Lee DJ, Manson JE, Aragaki AK, Mortimer JE, Phillips LS, Rohan T, Ho GYF, Saquib N, Shadyab AH, Nassir R, Rhee JJ, Hurria A, Chlebowski RT.

J Natl Cancer Inst. 2020 Feb 1;112(2):170-178. doi: 10.1093/jnci/djz069.

PMID:
31184362
16.

Low-Fat Dietary Pattern among Postmenopausal Women Influences Long-Term Cancer, Cardiovascular Disease, and Diabetes Outcomes.

Prentice RL, Aragaki AK, Howard BV, Chlebowski RT, Thomson CA, Van Horn L, Tinker LF, Manson JE, Anderson GL, Kuller LE, Neuhouser ML, Johnson KC, Snetselaar L, Rossouw JE.

J Nutr. 2019 Sep 1;149(9):1565-1574. doi: 10.1093/jn/nxz107.

17.

Reply to F. Conforti et al.

Pan K, Bosserman L, Chlebowski RT.

J Clin Oncol. 2019 Jul 20;37(21):1840-1841. doi: 10.1200/JCO.19.01133. Epub 2019 Jun 7. No abstract available.

PMID:
31173556
18.

Weight loss, diet composition and breast cancer incidence and outcome in postmenopausal women.

Pan K, Luo J, Aragaki AK, Chlebowski RT.

Oncotarget. 2019 May 3;10(33):3088-3092. doi: 10.18632/oncotarget.26864. eCollection 2019 May 3.

19.

Ovarian Suppression in Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.

Pan K, Bosserman LD, Chlebowski RT.

J Clin Oncol. 2019 Apr 10;37(11):858-861. doi: 10.1200/JCO.18.01360. Epub 2019 Feb 11. No abstract available.

PMID:
30742565
20.

Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors.

Xu X, Chlebowski RT, Shi J, Barac A, Haque R.

Breast Cancer Res Treat. 2019 Apr;174(3):785-794. doi: 10.1007/s10549-018-05086-8. Epub 2019 Jan 18.

PMID:
30659431
21.

Persistent vasomotor symptoms and breast cancer in the Women's Health Initiative.

Chlebowski RT, Mortimer JE, Crandall CJ, Pan K, Manson JE, Nelson R, Johnson KC, Vitolin MZ, Lane D, Wactawski-Wende J, Kwan K, Stefanick ML.

Menopause. 2018 Dec 28;26(6):578-587. doi: 10.1097/GME.0000000000001283.

PMID:
30601454
22.

Interaction of body mass index or waist-to-hip ratio and sun exposure associated with nonmelanoma skin cancer: A prospective study from the Women's Health Initiative.

Chan AA, Noguti J, Pak Y, Qi L, Caan B, Going S, Han J, Chlebowski RT, Lee DJ.

Cancer. 2019 Apr 1;125(7):1133-1142. doi: 10.1002/cncr.31810. Epub 2018 Dec 11.

23.

Association of Body Fat and Risk of Breast Cancer in Postmenopausal Women With Normal Body Mass Index: A Secondary Analysis of a Randomized Clinical Trial and Observational Study.

Iyengar NM, Arthur R, Manson JE, Chlebowski RT, Kroenke CH, Peterson L, Cheng TD, Feliciano EC, Lane D, Luo J, Nassir R, Pan K, Wassertheil-Smoller S, Kamensky V, Rohan TE, Dannenberg AJ.

JAMA Oncol. 2019 Feb 1;5(2):155-163. doi: 10.1001/jamaoncol.2018.5327.

24.

Adiposity, history of diabetes, and risk of pancreatic cancer in postmenopausal women.

Arthur R, Kabat GC, Kim MY, Ho GYF, Chlebowski RT, Pan K, Rohan TE.

Ann Epidemiol. 2019 Jan;29:23-29.e1. doi: 10.1016/j.annepidem.2018.09.005. Epub 2018 Sep 22.

PMID:
30449532
25.

Breast Cancer Outcomes in a Racially and Ethnically Diverse Cohort of Insured Women.

Haque R, Xu X, Shi J, Kwan ML, Chlebowski RT.

Ethn Dis. 2018 Oct 18;28(4):565-574. doi: 10.18865/ed.28.4.565. eCollection 2018 Fall.

26.

Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.

Chlebowski RT, Pan K.

N Engl J Med. 2018 Oct 25;379(17):1684. doi: 10.1056/NEJMc1810514. No abstract available.

PMID:
30358972
27.

Estrogen alone and joint symptoms in the Women's Health Initiative randomized trial.

Chlebowski RT, Cirillo DJ, Eaton CB, Stefanick ML, Pettinger M, Carbone LD, Johnson KC, Simon MS, Woods NF, Wactawski-Wende J.

Menopause. 2018 Nov;25(11):1313-1320. doi: 10.1097/GME.0000000000001235.

PMID:
30358728
28.

Notice of Retraction and Replacement. Tseng et al. Association of cataract surgery with mortality in older women: findings from the Women's Health Initiative. JAMA Ophthalmol. 2018;136(1):3-10.

Tseng VL, Chlebowski RT, Yu F, Cauley JA, Li W, Thomas F, Virnig BA, Coleman AL.

JAMA Ophthalmol. 2018 Nov 1;136(11):1313-1314. doi: 10.1001/jamaophthalmol.2018.3347. No abstract available.

PMID:
30352119
29.

Weight loss and breast cancer incidence in postmenopausal women.

Chlebowski RT, Luo J, Anderson GL, Barrington W, Reding K, Simon MS, Manson JE, Rohan TE, Wactawski-Wende J, Lane D, Strickler H, Mosaver-Rahmani Y, Freudenheim JL, Saquib N, Stefanick ML.

Cancer. 2019 Jan 15;125(2):205-212. doi: 10.1002/cncr.31687. Epub 2018 Oct 8.

30.

Estrogen metabolism in menopausal hormone users in the women's health initiative observational study: Does it differ between estrogen plus progestin and estrogen alone?

Falk RT, Manson JE, Barnabei VM, Anderson GL, Brinton LA, Rohan TE, Cauley JA, Chen C, Coburn SB, Pfeiffer RM, Reding KW, Sarto GE, Wentzensen N, Chlebowski RT, Xu X, Trabert B.

Int J Cancer. 2019 Feb 15;144(4):730-740. doi: 10.1002/ijc.31851. Epub 2018 Nov 1.

31.

Association of 25-hydroxyvitamin D levels and cutaneous melanoma: A nested case-control study of the Women's Health Initiative Observation Study.

Kwon GP, Gamba CS, Stefanick ML, Swetter SM, Li S, Shi RZ, Clarke CA, Feldman D, Millen AE, Messina C, Shikany JM, Manson JE, Chlebowski RT, Tang JY.

J Am Acad Dermatol. 2018 Jul;79(1):145-147. doi: 10.1016/j.jaad.2017.05.037. No abstract available.

PMID:
29908819
32.

Stratified Probabilistic Bias Analysis for Body Mass Index-related Exposure Misclassification in Postmenopausal Women.

Banack HR, Stokes A, Fox MP, Hovey KM, Cespedes Feliciano EM, LeBlanc ES, Bird C, Caan BJ, Kroenke CH, Allison MA, Going SB, Snetselaar L, Cheng TD, Chlebowski RT, Stefanick ML, LaMonte MJ, Wactawski-Wende J.

Epidemiology. 2018 Sep;29(5):604-613. doi: 10.1097/EDE.0000000000000863.

33.

Association of Low-Fat Dietary Pattern With Breast Cancer Overall Survival: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trial.

Chlebowski RT, Aragaki AK, Anderson GL, Simon MS, Manson JE, Neuhouser ML, Pan K, Stefanic ML, Rohan TE, Lane D, Qi L, Snetselaar L, Prentice RL.

JAMA Oncol. 2018 Oct 1;4(10):e181212. doi: 10.1001/jamaoncol.2018.1212. Epub 2018 Oct 11. Erratum in: JAMA Oncol. 2019 Apr 1;5(4):580.

34.

Impact of hormone therapy on Medicare spending in the Women's Health Initiative randomized clinical trials.

Shreibati JB, Manson JE, Margolis KL, Chlebowski RT, Stefanick ML, Hlatky MA.

Am Heart J. 2018 Apr;198:108-114. doi: 10.1016/j.ahj.2017.12.016. Epub 2017 Dec 27.

35.

Serum glucose and insulin and risk of cancers of the breast, endometrium, and ovary in postmenopausal women.

Kabat GC, Kim MY, Lane DS, Zaslavsky O, Ho GYF, Luo J, Nicholson WK, Chlebowski RT, Barrington WE, Vitolins MZ, Lin X, Liu S, Rohan TE.

Eur J Cancer Prev. 2018 May;27(3):261-268. doi: 10.1097/CEJ.0000000000000435.

PMID:
29438162
36.

Breast cancer survivorship: state of the science.

Pan K, Hurria A, Chlebowski RT.

Breast Cancer Res Treat. 2018 Apr;168(3):593-600. doi: 10.1007/s10549-017-4650-5. Epub 2018 Jan 13. Review.

PMID:
29332134
37.

Postmenopausal Fracture History and Survival After Reproductive Cancer Diagnosis.

Newcomb PA, Adams SV, Mayer S, Passarelli MN, Tinker L, Lane D, Chlebowski RT, Crandall CJ.

JNCI Cancer Spectr. 2018 Jan;2(1):pky001. doi: 10.1093/jncics/pky001. Epub 2018 Mar 21.

38.

Post-Stroke Cancer Risk among Postmenopausal Women: The Women's Health Initiative.

Sealy-Jefferson S, Cote ML, Chlebowski RT, Rexrode KM, Simon MS.

Womens Health Issues. 2018 Jan - Feb;28(1):29-34. doi: 10.1016/j.whi.2017.10.012. Epub 2017 Dec 2.

PMID:
29199053
39.

Serum lipids and risk of obesity-related cancers in postmenopausal women.

Kabat GC, Kim MY, Chlebowski RT, Vitolins MZ, Wassertheil-Smoller S, Rohan TE.

Cancer Causes Control. 2018 Jan;29(1):13-24. doi: 10.1007/s10552-017-0991-y. Epub 2017 Dec 2.

PMID:
29197994
40.

Complexity of intermittent letrozole adjuvant therapy.

Chlebowski RT, Pan K.

Lancet Oncol. 2018 Jan;19(1):13-15. doi: 10.1016/S1470-2045(17)30854-9. Epub 2017 Nov 17. No abstract available.

PMID:
29158010
41.

Intentional weight loss and cancer risk.

Luo J, Hendryx M, Chlebowski RT.

Oncotarget. 2017 Sep 6;8(47):81719-81720. doi: 10.18632/oncotarget.20671. eCollection 2017 Oct 10. No abstract available.

42.

Association of Cataract Surgery With Mortality in Older Women: Findings from the Women's Health Initiative.

Tseng VL, Chlebowski RT, Yu F, Cauley JA, Li W, Thomas F, Virnig BA, Coleman AL.

JAMA Ophthalmol. 2018 Jan 1;136(1):3-10. doi: 10.1001/jamaophthalmol.2017.4512.

43.

Metabolic Obesity Phenotypes and Risk of Breast Cancer in Postmenopausal Women.

Kabat GC, Kim MY, Lee JS, Ho GY, Going SB, Beebe-Dimmer J, Manson JE, Chlebowski RT, Rohan TE.

Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1730-1735. doi: 10.1158/1055-9965.EPI-17-0495. Epub 2017 Sep 22.

44.

Cardiovascular disease and mortality after breast cancer in postmenopausal women: Results from the Women's Health Initiative.

Park NJ, Chang Y, Bender C, Conley Y, Chlebowski RT, van Londen GJ, Foraker R, Wassertheil-Smoller S, Stefanick ML, Kuller LH.

PLoS One. 2017 Sep 21;12(9):e0184174. doi: 10.1371/journal.pone.0184174. eCollection 2017.

45.

Low-fat Dietary Pattern and Pancreatic Cancer Risk in the Women's Health Initiative Dietary Modification Randomized Controlled Trial.

Jiao L, Chen L, White DL, Tinker L, Chlebowski RT, Van Horn LV, Richardson P, Lane D, Sangi-Haghpeykar H, El-Serag HB.

J Natl Cancer Inst. 2018 Jan 1;110(1). doi: 10.1093/jnci/djx117.

46.

Serum 25-hydroxyvitamin D concentrations and lung cancer risk in never-smoking postmenopausal women.

Cheng TD, Song X, Beresford SAA, Ho GYF, Johnson KC, Datta M, Chlebowski RT, Wactawski-Wende J, Qi L, Neuhouser ML.

Cancer Causes Control. 2017 Oct;28(10):1053-1063. doi: 10.1007/s10552-017-0956-1. Epub 2017 Sep 12.

47.

Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials.

Manson JE, Aragaki AK, Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Chlebowski RT, Howard BV, Thomson CA, Margolis KL, Lewis CE, Stefanick ML, Jackson RD, Johnson KC, Martin LW, Shumaker SA, Espeland MA, Wactawski-Wende J; WHI Investigators.

JAMA. 2017 Sep 12;318(10):927-938. doi: 10.1001/jama.2017.11217.

48.

Methodological considerations for disentangling a risk factor's influence on disease incidence versus postdiagnosis survival: The example of obesity and breast and colorectal cancer mortality in the Women's Health Initiative.

Cespedes Feliciano EM, Prentice RL, Aragaki AK, Neuhouser ML, Banack HR, Kroenke CH, Ho GYF, Zaslavsky O, Strickler HD, Cheng TD, Chlebowski RT, Saquib N, Nassir R, Anderson G, Caan BJ.

Int J Cancer. 2017 Dec 1;141(11):2281-2290. doi: 10.1002/ijc.30931. Epub 2017 Aug 31.

49.

Association between Dietary Energy Density and Obesity-Associated Cancer: Results from the Women's Health Initiative.

Thomson CA, Crane TE, Garcia DO, Wertheim BC, Hingle M, Snetselaar L, Datta M, Rohan T, LeBlanc E, Chlebowski RT, Qi L.

J Acad Nutr Diet. 2018 Apr;118(4):617-626. doi: 10.1016/j.jand.2017.06.010. Epub 2017 Aug 17.

50.

Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study.

Crandall CJ, Hovey KM, Andrews CA, Chlebowski RT, Stefanick ML, Lane DS, Shifren J, Chen C, Kaunitz AM, Cauley JA, Manson JE.

Menopause. 2018 Jan;25(1):11-20. doi: 10.1097/GME.0000000000000956.

Supplemental Content

Loading ...
Support Center